Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients

The levels of messenger RNA (mRNA) transcription of FOXP3, IFN-γ, TNF, IL-6 and COX-2 from both COVID-19 infected and control subjects were evaluated using SYBRTM green real-time polymerase chain reaction (RT-PCR). Severe/critical cases showed significantly lower lymphocyte counts and higher neutrop...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 563; pp. 74 - 81
Main Authors Abdelhafiz, Ahmed S., Fouad, Mariam A., Sayed-Ahmed, Mohamed M., Kamel, Mahmoud M., Ali, Asmaa, Fouda, Merhan, Khalil, Mahmoud A., Abdel-Moneim, Ahmed S., Kamal, Lamyaa M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2021
Subjects
Online AccessGet full text
ISSN0042-6822
1096-0341
1096-0341
DOI10.1016/j.virol.2021.08.012

Cover

More Information
Summary:The levels of messenger RNA (mRNA) transcription of FOXP3, IFN-γ, TNF, IL-6 and COX-2 from both COVID-19 infected and control subjects were evaluated using SYBRTM green real-time polymerase chain reaction (RT-PCR). Severe/critical cases showed significantly lower lymphocyte counts and higher neutrophil counts than the mild or moderate cases. There were significantly lower levels of mRNA expressions of IFN-γ, TNFα and FOXP3 in COVID-19 patients than in the control group. On the other hand, IL-6 and COX-2 expressions were significantly higher in patients suffering from severe disease. FOXP3 expressions were correlated with the severities of hypoxia and were excellent in predicting the disease severity. This was followed by the IL-6, COX-2 and TNFα expressions. FOXP3 expression was the only biomarker to show a significant correlation with patient mortality. It was concluded that SARS-CoV-2 infection is associated with the downregulation of FOXP3 and upregulations of IL-6 and COX-2. •The immunological response to SARS-CoV-2 infection is still obscure.•Low mRNA expressions of IFN-γ, TNFα and FOXP3 were detected in COVID-19 patients.•IL-6 and COX-2 are highly expressed in patients suffering from severe COVID-19.•FOXP3 can be used as a potential biomarker for predicting disease severity.•COVID-19 coincides with downregulation of FOXP3 and upregulations of IL-6 and COX-2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0042-6822
1096-0341
1096-0341
DOI:10.1016/j.virol.2021.08.012